Efficacy of rituximab for patients with anti-glomerular basement membrane disease

Liangliang Chen; Yiting Chen; Anqi Ni; Yuxin Lin; Xiaoqi Shen; Jianghua Chen; Fei Han

doi:10.1093/ndt/gfad268

Efficacy of rituximab for patients with anti-glomerular basement membrane disease

Nephrol Dial Transplant. 2024 Mar 27;39(4):720-723. doi: 10.1093/ndt/gfad268.

Authors

Liangliang Chen^{1

2

3

4}, Yiting Chen^{1

2

3

4}, Anqi Ni^{1

2

3

4}, Yuxin Lin^{1

2

3

4}, Xiaoqi Shen^{1

2

3

4}, Jianghua Chen^{1

2

3

4}, Fei Han^{1

2

3

4}

Affiliations

¹ Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
² Institute of Nephrology, Zhejiang University, Hangzhou, Zhejiang, China.
³ Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang Province, Hangzhou, Zhejiang, China.
⁴ Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, Zhejiang, China.

PMID: 38130241
DOI: 10.1093/ndt/gfad268

No abstract available

MeSH terms

Anti-Glomerular Basement Membrane Disease* / therapy
Autoantibodies
Humans
Plasma Exchange
Rituximab

Substances

Rituximab
Autoantibodies

Grants and funding

2020C03034/Primary Research and Development Plan of Zhejiang Province